Gilead Sciences Chief Commercial & Corporate Affairs Officer Sells 3,000 Shares Under Rule 10b5-1 Plan

Executive Summary

On October 16, 2026, a Form 4 was filed for GILEAD SCIENCES, INC. ($GILD) indicating that Johanna Mercier, Chief Commercial & Corporate Affairs Officer, executed a sale of 3,000 shares of Common Stock on October 15, 2026.

Transaction Details

• Security: Common Stock
• Transaction Type: Open Market Sale (Code: S)
• Shares Sold: 3,000
• Execution Price: $156.22 per share
• Total Gross Proceeds: $468,660.00
• Nature of Ownership: Direct
• Post-Transaction Beneficial Ownership: 113,684 shares

Strategic & Contextual Overview

• Trading Plan: The transaction was conducted in accordance with a pre-arranged Rule 10b5-1 trading plan adopted on February 20, 2025. Pre-scheduled plans mitigate concerns of trading on material non-public information.
• Holding Impact: The 3,000 shares sold represent approximately 2.57% of Mercier's direct equity holdings prior to the sale (116,684 shares), leaving her with substantial equity alignment of 113,684 shares.
• Significance Level: Low, reflecting routine execution under a pre-established 10b5-1 plan representing a minor portion of total equity holdings.